| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2025 | 19 May 2025 |
| Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Audited Financial Results for quarter and year ended on 31st March 2025 Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at their meeting held on Monday, the26th day of May, 2025 at 4:30 P.M. has inter- alia: (1) Approved the Audited Financial Results for quarter and year ended 31st March, 2025. We enclose here with a copy of the approved Audited Financial Results along with the Auditors Report with unmodified opinions on the aforesaid Audited Financial Results issued by M/s M.A. SHAH & Co., Chartered Accountants (FRN: 112630W), Statutory Auditors of the Company as Annexure-A. (2) Re-Appointment of M/s D.V. Shah, (Membership No.034294), Chartered Accountants( FRN No. 109551W ), as Internal Auditor of the Company for the Financial Year 2025-26. and others (As Per BSE Announcement dated on 26.05.2025) | ||
| Board Meeting | 4 Feb 2025 | 27 Jan 2025 |
| GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve Unaudited Financial Results of the company for the Quarter ended on 31st December 2024. Unaudited Financial Results for quarter ended on 31.12.2024 (As Per BSE Announcement Dated on: 04/02/2025) | ||
| Board Meeting | 28 Oct 2024 | 18 Oct 2024 |
| GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2024 Outcome of Board Meeting held on 28th October, 2024 at 06:00 pm (As per BSE Announcement dated on: 28/10/2024) | ||
| Board Meeting | 9 Aug 2024 | 2 Aug 2024 |
| GUJARAT TERCE LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve consideration of Unaudited Financial Results for the quarter ended 30th June 2024 and ensuing 39th AGM Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing RegulationsT) read with Schedule 1T to the said Regulations, this is to inform you that the Board of Directors of the Company, at its Meeting held today i.e., Friday, 09 August, 2024 which commenced at 4:00 p.m. and concluded at 5:00 p.m. for approval of Unaudited Standalone Financial Results for the Quarter ended on June 30, 2024 and decide date of Ensuing AGM (As per BSE Announcement Dated on 09/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.